Most Recent
Mastercard can appeal privilege waiver ruling in ACCC’s case
Mastercard can pursue an appeal of a ruling for the competition regulator requiring the credit card giant to hand over communications about its agreements with retailers, which are at the centre of a misuse of market power case.
ACCC opposes Kegstar’s bid to acquire competitor’s keg pooling assets
The ACCC will oppose US keg services business Kegstar's plans to acquire the assets of Konvoy Holdings, saying it would substantially lessen competition for keg pooling services.
Fletcher Building unit points finger at BGC in pipes class action
Iplex Pipelines has argued builder BGC should hand over documents relating to its estimate that it will cost $123 million to fix homes it claims were fitted with faulty pipes manufactured by the Fletcher Building unit.
eToro settles with ASIC in novel suit over CFDs
The court will not get a chance to rule on the design and distribution obligations in the marketing of contracts for difference, after the Australian Securities and Investments Commission reached an agreement with eToro to resolve the first case of its kind. 
Apple, Google say orders sought by Epic Games go ‘well beyond’ case
In the wake of a judgment that Apple and Google misused their market power in running their app stores, the tech giants are fighting injunctions proposed by Epic Games, which they say go beyond the case argued at trial.
ACCC wants in on developer’s High Court case over NSW Ports
Having lost a challenge to privatisation agreements by NSW Ports, the competition regulator wants to intervene in a High Court appeal by Mayfield Developments, which failed in its own case against the port authority.
Cosmetic surgeon too ill to comply with class action timetable, court told
The Victorian Supreme Court has granted cosmetic surgeon Daniel Lanzer an extension to provide discovery  in a class action against him and his clinic after hearing he was facing medical issues.
4D Medical sues Cyclopharm over ‘misleading’ statements elicited by ‘fake’ question
ASX-listed biotech 4D Medical has sued competitor Cyclopharm alleging the company made false, misleading and malicious statements about its rival during an online webinar prompted by a "fake" question.
Pentana can’t withdraw admissions in misuse of market power case
A judge has declined car dealer software supplier Pentana's bid to withdraw admissions made over four years ago in a dispute with competitor Titan DMS.
Elders’ $475M bid for Delta Agribusiness wins OK with store sell-off
The ACCC will not stand in the way of Elders’ $475 million takeover of rival farm supplier Delta Agribusiness, after the agribusiness giant provided an undertaking to divest six Delta stores in Western Australia.